Merck

Merck & Co. is a global biopharmaceutical company based in New Jersey that discovers, develops, and markets medicines and vaccines to treat cancer, infectious diseases, autoimmune disorders, and other conditions. The company maintains a strong cancer portfolio anchored by an immuno-oncology therapy platform led by Keytruda and a growing vaccine business including Gardasil for human papillomavirus. Its research arm, Merck Research Laboratories, focuses on discovering and developing therapies for cancer and neurodegenerative diseases. Merck also markets animal health products. Through its science-driven approach, Merck aims to deliver innovative products and therapies that improve patient outcomes worldwide.

Kenneth Frazier

CEO and Chairman of the Board

Maxwell Kahn

Managing Director

David Rubin

Founding Partner and Managing Director

Dave Stevenson

Managing Director

Prem Tumkosit

Managing Director

Joe Volpe

Managing Director and Founding Partner

Past deals in South Dakota

SAb Biotherapeutics

Series B in 2020
SAB Biotherapeutics is a clinical-stage biopharmaceutical company established in 2014, headquartered in Sioux Falls, South Dakota with additional offices in Cambridge, Massachusetts. The company specializes in developing immunotherapies using its proprietary DiversitAb platform, which employs transchromosomic cattle to produce large quantities of targeted human polyclonal antibodies without relying on human plasma or serum. SAB's pipeline includes therapies for conditions such as Type 1 diabetes (SAB-142), seasonal influenza (SAB-176), and Middle East Respiratory Syndrome Coronavirus (MERS-CoV, SAB-301).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.